November 7, 2016
For over 35 years, the “14-Day Rule,” prohibiting in vitro experimentation on embryos beyond 14 days, stood as an ethical line in the sand for embryo research around the world. Throughout the arc of the rule’s existence it had not been questioned, as scientists had been unable to grow embryos in vitro either up to, or beyond, 14 days; a practical limitation that served as a backstop to the ethical rule. However, in May 2016, labs in the U.S. and the U.K. were the first to report being able to sustain human embryos in vitro for up to 13 days. This development and other advances in in vitro research involving organized, embryo-like cellular structures have raised a number of questions about the rule, its genesis, application, and future scope. This conference convened experts in bioethics, stem cell research, embryology, and law to discuss the ethical underpinnings and future scope of the rule. Questions discussed included:
- What are the historical, ethical and scientific rationales for establishing the 14-Day Rule?
- Should the 14-Day Rule be revisited in light of recent advances?
- Should the 14-Day Rule even apply to research involving the in vitro culture of embryo-like cellular structures?
This event was free and open to the public.
This event was sponsored by the Harvard University Office of the Vice Provost for Research, the Edmond J. Safra Center for Ethics at Harvard University, and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, and the Harvard Stem Cell Institute, with support from the International Society for Stem Cell Research and the Center for Bioethics at Harvard Medical School.
View the full agenda and learn more on the website: http://petrieflom.law.harvard.edu/events/details/advances-in-in-vitro-research-and-the-14-day-rule.
Statistical modeling in pharmaceutical research and development.
Gist Croft, "Self-organization of the in vitro attached human embryo and its implications"
1. Self-organization of the in vitro attached human embryo and its implications
Gist Croft, PhD
Brivanlou Laboratory of Stem Cell Biology and Molecular Embryology
The Rockefeller University
The Ethics of Early Embryo Research and the Future of the 14 Day Rule
Petrie-Flom Center, Harvard Law School
11 / 7 / 2016
2. Derived from the ICM of the blastocyst
Evans, Martin, Kauffman, 1981 (mouse), Thomson, 1998 (human)
iPSCs: reprogram somatic cells with pluripotency genes, Yamanaka, 2006
Pluripotent
Self-renewing
Experimental model of human development
Make cell types for cell-replacement and disease-modeling
Embryonic Stem Cells: Origins and Utility
NIH
Kang et al, 2009
(iPS mouse)
Need to understand early cell fate choices in vivo, origin and trajectory of ES cells
3. Human embryo development after implantation remains a black box
Zygote
D1
2-cell
D1-D2
4-cell
D2
Multi-cell
D3
Morula
D3-D4
Blastocyst
D5-6
Stage:
DPF:
Post-blastocyst
D7+
(B. Behr, Stanford IVF)
4. CS4 (DPF7) CS5C (DPF12) CS6 (DPF14-17): gastrulation
Mouse
Organizational landmarks of pre-gastrulation development: mouse vs. human
Mouse
Egg cylinder
Human
Germ
disc
Attached blastocyst
CS5B (DPF9)
Bilaminar disc Trilaminar disc
(Langman’s Medical Embryology; Human Embryology and Teratology)
5. New ex vivo models of
Be
Morris et al, 2012; Bedzhov et al, 2014a,b: Zernicke-Goetz LabKang et al, 2013; Schrode et al, 2014: Hadjantonakis Lab
New ex vivo approaches provide insights into early mouse embryo development
First and second cell fate decisions tissue morphogenesis and self organization
6. Can we adapt approach for in vitro culture of human blastocysts?
2013 Rockefeller IRB Protocol approved
culture
??
thaw
zona pellucida
removed
cryopreserved
blastocysts
blastocyst
2005 National Academies of Science 2005 and 2010 Stem Cell Research Guidelines:
bioethical consensus and mandate for in vitro culture up to DPF14 or primitive streak
2016 Deglincerti and Croft, et al. Nature
2104 consented donation of surplus IVF embryos for culture experiments
2015 first experiments
7. Human embryos attach and develop in vitro
DPF6 DPF8 DPF10 DPF12 DPF14
Deglincerti and Croft et al, Nature 2016
8. In vitro culture of the human blastocysts – DPF6
Scale bar = 50 um
ICM
Trophectoderm
10. The molecular signature of the human blastocyst is more
similar to the cow than the mouse
Mouse
blastocyst
Cow
blastocyst
Human
blastocyst
(Rossant, 2015)
11. Morphology: Phalloidin
ICM: OCT4; GATA6
TE: GATA3
DPF6
Number of cells: 267 ± 37 (n=8)
- GATA3 marks TE
- ICM cell-sorting incomplete
Deglincerti and Croft et al, Nature 2016
12. Morphology: Phalloidin, DAPI
ICM: NANOG; SOX17
DPF6
Number of cells: 267 ± 37 (n=8)
- Epi and PE specified
- ICM cell-sorting incomplete
13. Divergent transcriptional profile of mouse vs. human TE
ICM determinants similar
TE: GATA3+ OCT4LOW GATA6 LOW CDX2 LOW/VAR/CYTO
Mouse
Human
TE: CDX2+ GATA3+
ICM: NANOG OCT4 HI GATA6 HI/LOW SOX17
ICM: NANOG OCT4 HI GATA6 HI/LOW SOX17
Cartoon adapted from Nadine Schrode, Néstor Saiz, Stefano Di Talia, Anna-Katerina Hadjantonakis, MSKCC
15. Attachment occurs at ~DPF7.5, always on the side of the ICM
in vitro
in vivo
Deglincerti and Croft et al, Nature 2016
16. DPF8
Number of cells: 268 ± 8 (n=4)
ICM: OCT4; GATA6
TE: GATA3
- Compaction of the Epiblast
- Physical sorting of Epi and PE Deglincerti and Croft et al, Nature 2016
17. Mouse
Human
after attachment
before attachment
Second cell fate decision, ICM Epiblast vs. PE:
similar determinants; delay in human relative to mouse
Adapted from Nadine Schrode, Néstor Saiz, Stefano Di Talia, Anna-Katerina Hadjantonakis, MSKCC
DPF8 profiles
Epiblast
NANOG
OCT4 HI
PE
GATA6
SOX17
TE
GATA3
CDX2 LOW/VAR
18. DPF10
Number of cells: 890 ± 226 (n=4)
Morphology: Phalloidin
ICM: OCT4; GATA6
TE: GATA3; CDX2
Deglincerti and Croft et al, Nature 2016
20. Yolk sac TE
Yolk sac cavity
ICM: OCT4; GATA6
TE: GATA3; CDX2
DPF10: Yolk sac cavity, lined by a newly described human-specific
cell type (yolk sac TE cells)
OCT4LO/GATA6LO/CDX2+
Morphology: Phalloidin
CS5B (DPF9)
Bilaminar germ disc
CS5C (DPF12)
Deglincerti, Croft et al, Nature 2016
21. DPF10: First expression of CD24 in embryo; exclusively marks Epiblast
GATA3
CD24
GATA6
OCT4
Deglincerti, Croft et al, Nature 2016
DPF10: First timepoint Epi cells match hESC
22. DPF8: Second stage of TE lineage progression
ICM: OCT4
TE: CK7; HCGB
Deglincerti and Croft et al, Nature 2016
23. DPF10: Diversification of TE lineage: CTB and SCTB
ICM: OCT4
TE: CK7; HCGB
Deglincerti and Croft et al, Nature 2016
24. DPF12: further specialization of TE lineages
ICM: OCT4
TE: CK7; HCGB
DAPI GATA3 Phalloidin GATA3 Phalloidin HCGBDAPI DAPI
Deglincerti and Croft et al, Nature 2016
CS5C (DPF12)
25. Early and autonomous diversification of TE lineages in vitro
Different blastocyst transcriptional profiles and delayed ICM cell-sorting vs. mouse
ysTE, a new human-specific embryonic cell type
Autonomous formation of species-specific amniotic and yolk sac cavities
Embryo self-organization in the absence of maternal input after attachment
Self-organization of the in vitro attached human embryo
DPF10+ epiblast: new ex vivo benchmark for origin of hESCs
26. Future Directions
Reproductive and maternal fetal medicine
new measures of embryo quality
placental disorders
maternal fetal interface, immune tolerance
comparative embryology
Developmental roadmap of stem cell fate
epiblast: naïve, primed, germ layers and cells
PE
TE
Anticipation of gastrulation
molecular and geometric controls
prepatterning
27. Warmflash, et al, Nature Methods 2014; Etoc, et al, Developmental Cell 2016
Unresolved questions in embryonic stem cell biology
Why do hESC apparently differentiate in forward
and reverse (form TE-like cells)?
Why are naïve human pluripotent stem cells
elusive and what would they look like?
Day 0 Day 2, BMP4 treatment
OCT4DAPI CDX2 BRA SOX2
Human ES cell colony
28. Blastocyst
Pluripotent hESC 2days BMP4 induced “gastrulation” model
Comparison of cell fate regulation ex vivo and in vitro
Molecular markers
Signalling pathways
Cell polarity
Tissue architecture
DPF10
DPF12
29. What happens after DPF12?
ICM: OCT4
TE: CK7; HCGB
DAPI GATA3 Phalloidin GATA3 Phalloidin HCGBDAPI DAPI
Deglincerti, Croft et al, Nature 2016
CS5C (DPF12)
CS6 (DPF14-17): gastrulation
30. Morphology: Phalloidin
ICM: OCT4; GATA6
TE: GATA3
Croft et al, unpublished
CS6 (DPF14-17):
gastrulation
DPF14 Number of cells: 1012 ± 127 (n=8)
Transition to a volcano-shaped structure
Horseshoe distribution of cells
Centrifugal dispersion of cells
31. AcknowledgementsBlastocyst donors and IVF clinic
Alessia Deglincerti: co-first author
Ali Brivanlou and Eric Siggia
Magdalena Zernicka-Goetz
Kat Hadjantonakis,
Lauren Pietila Stephanie Tse, Corbyn Nchako
Cecilia Pelligrini: technical support
RU BIRC: Alison North, Pablo Ariel,
Kaye Thomas, Tao Tong
Amy Wilkerson: bioethics and IRB Protocol
Arlene Hurley and Donna Brassil
Hospital/IRB facilitation office
Supported by Starr foundation Tri-I Stem Cell Initiative grant and Rockefeller Private funds